Over 10 years experience of Traceability Solutions
By pharmatrax
Category: News
No Comments
WASHINGTON, DC (WICS/WRSP) — A blood pressure medicine that has dealt with at least four recalls this year is facing yet another. This time, the recall…
By pharmatrax
Category: Technoloy
No Comments
Cassius Marcellus Coolidge’s Dogs Playing Poker may have had you fooled – but really, dogs don’t smoke cigars, cigarettes or pipes. However, like humans that do not…
By pharmatrax
Category: News
No Comments
The FDA posted a public missive alongside a warning letter to a Chinese OTC drug manufacturer, highlighting the efforts it had been making to address…
By pharmatrax
Category: Technoloy
No Comments
The world is in the midst of fourth industrial revolution where we are at the turning point of an overall collection of digital advancements like…
By pharmatrax
Category: Technoloy
No Comments
Prescription medications are dangerous. Yes, they can cure certain infections or control chronic conditions, but there is a reason some pharmaceuticals cannot be bought over…
By pharmatrax
Category: Technoloy
No Comments
3D tissue printing startup Prellis Biologics has assembled $8.7 million in new funding alongside positive news from the first transplantation of its vascular tissue scaffolds…
By pharmatrax
Category: Technoloy
No Comments
Master’s student and Marshall Scholar Kyle Swanson uses computer science to help make drug development more efficient. Pharmaceutical companies spend a lot of time testing…
By pharmatrax
Category: News
No Comments
The Khyber Pakhtunkhwa Provincial Quality Control Board (PQCB) has ordered to lodged 11 FIRs against sellers of fake and sub-standard medicines while several cases has…
By pharmatrax
Category: News
No Comments
A US court has ordered generic drug makers including Mylan, Dr Reddy’s Laboratories, Aurobindo Pharma, and Torrent Pharma to stop selling a copy of Gilenya,…
By pharmatrax
Category: Technoloy
No Comments
Sanofi will apply Google’s artificial intelligence (AI) and cloud computing capabilities toward developing new drugs, through a collaboration whose value was not disclosed. The companies…